How well do we manage non-muscle invasive bladder tumors? A UK audit of real-life practices.

Petros SountoulidesWilbert Fana MutombaEmmanouil C BourasJieqi LimAndreas BourdoumisArun Jain

Published in: Urologia (2020)

One in two patients will have a re-TUR, and approximately one in two patients will have tumor on re-TUR. Single immediate chemotherapy instillations after TURBT are underutilized. The presence of carcinoma in situ on initial TURBT and tumor size were predictors of early recurrences.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
healthcare
peritoneal dialysis
primary care
skeletal muscle
patient reported outcomes
spinal cord injury
squamous cell carcinoma
rectal cancer
patient reported
urinary tract